Randomised, placebo-controlled, crossover trial of sildenafil citrate in the treatment of erectile dysfunction following external beam radiation treatment of prostate cancer

Journal of Medical Imaging and Radiation Oncology

Volumn 54, Issue 3, 2010, Pages 224-228

  Harrington, C ^a   Campbell, G ^b   Wynne, C ^a   Atkinson, C ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Erectile dysfunction; Phosphodiesterase inhibitors; Prostatic neoplasms; Radiotherapy

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; FLUSHING; HEADACHE; HUMAN; INDIGESTION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL FUNCTION; SIDE EFFECT; TREATMENT OUTCOME; VISUAL DISORDER;

AGED; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLACEBO EFFECT; PROSTATIC NEOPLASMS; PURINES; RADIOTHERAPY, CONFORMAL; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 77953484776     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2010.02168.x     Document Type: Article

References (22)

1. Selected Health Statistics: Cancer deaths and new registrations 2005 & selected sites 2006 Cited 05 Dec 2008.] Available from http://www.nzhis.govt.nz/moh.nsf/pagesns/32#01
2. Bhatnagar V, Stewart ST, Huynh V, Jorgensen G, Kaplan RM. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate treatment. Prostate Cancer Prostatic Dis 2006 9: 136 146.
3. Miller DC, Sanda MG, Dunn RL et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005 23 (12 2772 2780.
4. Incrocci L, Koper PCM, Hop WCJ, et al. Sildenafil citrate (Viagra) and erectile dysfunction following external-beam radiotherapy for prostate cancer. A randomized, double-blind, placebo-controlled, cross-over study. Int J Radiat Oncol Biol Phys 2001 51: 1190 1195.
5. IncrocciL SC. A randomized, double-blind, placebo-controlled, crossover study to assess the efficacy of tadalafil (Cialis®) in the treatment of erectile dysfunction following 3d conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 2006 66 (2 439 444.
6. Merrick G, Butler W, Wallner K et al. Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005 62 (2 437 447.
7. Dubbelman YD, Dohle GR, Schroeder FH. Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome. Eur Urol 2006 50: 711 720.
8. Turner SL, Adams K, Bull CA, Berry MP. Sexual dysfunction after radical radiation therapy for prostate cancer: A prospective evaluation. Urology 1999 54 (1 124 129.
9. Korfage IJ, Essink-Bot M, Borsboom GJJM et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 2005 116: 291 296.
10. Namiki S, Ishidoya S, Tochigi T et al. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: Comparison with conventional and conformal radiotherapy. Jpn J Clin Oncol 2006 36 (4 224 230.
11. Ward-Smith P, Kapitan D. Quality of life among men treated with radiation therapy for prostate cancer. Urol Nurs 2005 25 (4 263 268.
12. Ohebshalom M, Parker M, Guhring P, Mulhall JP. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: Temporal considerations. J Urol 2005 174: 258 262.
13. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997 49: 822 830.
14. Incrocci L. Sexual function after external-beam radiotherapy for prostate cancer: What do we know?. Crit Rev Oncol Hematol 2006 57: 165 173.
15. Salonia A, Zanni G, Gallina A, et al. Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. Eur Urol 2006 50: 360 365.
16. Stephenson RA, Mori M, Hsieh Y et al. Treatment of erectile dysfunction following therapy for clinically localised prostate cancer: Patient reported use and outcomes from the seer prostate cancer outcomes study. J Urol 2005 174: 646 650.
17. Lamb DS, Denham JW, Mameghan H et al. Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer. Radiother Oncol 2003 68: 255 267.
18. Zelefsky M, Eid FJ. Elucidating the etiology of erectile dysfunction after definitive therapy of prostate cancer. Int J Radiation Oncology Biol Phys 1998 40 (1 128 133.
19. Mulhall J, Ahmed A, Parker M, Mohideen N. Hemodynamics of erectile dysfunction following external beam radiation for prostate cancer. J Sex Med 2005 2: 432 437.
20. Wilke DR, Parker C, Andonowski A et al. Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists. BJU Int 2006 97: 963 968.
21. Villeirs GM, De Meerleer GO. Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. Eur J Radiol 2007 63: 361 368.
22. Van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: A critical review. Radiother Oncol 2007 84: 107 113.